← Back to Search

Antimicrobial Agent

Silver Alginate for Central Line-Associated Bloodstream Infection

N/A
Waitlist Available
Led By Asif Khattak, MD
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

The purpose of this study is to determine whether silver alginate (Algidex) patch is effective in the prevention of central line infections in very low birth weight infants.

Eligible Conditions
  • Central Line-Associated Bloodstream Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The primary objective of this trial is to assess the efficacy of silver alginate dressing in reducing central line infections in VLBW infants
Secondary outcome measures
Medical dressing

Trial Design

1Treatment groups
Active Control
Group I: No interventionActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Baylor Research InstituteLead Sponsor
200 Previous Clinical Trials
202,926 Total Patients Enrolled
DeRoyal Industries, Inc.Industry Sponsor
5 Previous Clinical Trials
449 Total Patients Enrolled
Asif Khattak, MDPrincipal InvestigatorBaylor Health Care System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants
2009. "The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00964093.
All > Rsv
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top